Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of x rays on the sensitivity of CR-39 detectors to 2.4-MeV protons.

The Review of scientific instruments·2025
Same author

CO2 laser ablation of oral leukoplakia: with or without extension of margins?

La Clinica terapeutica·2020
Same author

Studies on the overproduction of indole-containing metabolites by a methanol-utilizing yeast : Hansenula polymorpha.

Applied biochemistry and biotechnology·2013
Same author

Microparticles prepared from biodegradable polyhydroxyalkanoates as matrix for encapsulation of cytostatic drug.

Journal of materials science. Materials in medicine·2013
Same author

Biosynthesis of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) containing a predominant amount of 3-hydroxyvalerate by engineered Escherichia coli expressing propionate-CoA transferase.

Journal of applied microbiology·2012
Same author

Are we prepared for animal cell technology in the 21st century?

Cytotechnology·2012
Same journal

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors.

Clinical pharmacology and therapeutics·2026
Same journal

Composite Endpoints in Contemporary Cardiovascular Trials: Trends in Phase 3 Trials and Key Issues in Regulatory Review.

Clinical pharmacology and therapeutics·2026
Same journal

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data.

Clinical pharmacology and therapeutics·2026
Same journal

Reply to: "The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient".

Clinical pharmacology and therapeutics·2026
Same journal

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Clinical pharmacology and therapeutics·2026
Same journal

Repurposing Registries: Completeness of Real-World Data for Regulatory and HTA Purposes in Three Cancer-Focused Registries.

Clinical pharmacology and therapeutics·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

BioMEMS: Forging New Collaborations Between Biologists and Engineers
07:26

BioMEMS: Forging New Collaborations Between Biologists and Engineers

Published on: November 1, 2007

8.7K

Leveraging Industry-Academia Collaborations in Adaptive Biomedical Innovation.

S R Stewart1, P W Barone1, A Bellisario2

  • 1Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Clinical Pharmacology and Therapeutics
|September 13, 2016
PubMed
Summary
This summary is machine-generated.

Pharmaceutical R&D productivity is stagnant. Companies are shifting towards external innovation, like the Sanofi-MIT Partnership, to foster collaboration and advance translational science effectively.

More Related Videos

Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

17.4K
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

8.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

BioMEMS: Forging New Collaborations Between Biologists and Engineers
07:26

BioMEMS: Forging New Collaborations Between Biologists and Engineers

Published on: November 1, 2007

8.7K
Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

17.4K
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
16:05

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools

Published on: October 1, 2007

8.1K

Area of Science:

  • Biomedical innovation and pharmaceutical R&D.

Background:

  • Pharmaceutical research and development (R&D) productivity has not seen broad improvement despite rapid biomedical advancements.
  • Companies face pressure to adapt to market and scientific changes, necessitating new product development and commercialization strategies.
  • There is a growing trend for firms to leverage external innovation, including federal R&D investments, talent, and infrastructure.

Purpose of the Study:

  • To examine the transition towards external innovation in the pharmaceutical industry.
  • To illustrate the effectiveness of collaborative, externally funded research initiatives.

Main Methods:

  • The Sanofi-MIT Partnership provided seed funding to MIT investigators for novel solution development.
  • Projects involved highly collaborative efforts with bidirectional information and material exchange.
  • Awards featured relatively small funding amounts and short time frames to ensure flexibility.

Main Results:

  • The partnership facilitated the development of novel solutions and approaches in areas relevant to Sanofi.
  • The collaborative model enabled adaptable and flexible advancement of translational science.
  • This approach demonstrated a viable model for external innovation in the pharmaceutical sector.

Conclusions:

  • External innovation models, exemplified by the Sanofi-MIT Partnership, are crucial for overcoming stagnant R&D productivity.
  • Collaborative, flexible, and externally funded initiatives can effectively advance translational science.
  • The pharmaceutical industry must embrace such transitions to maintain competitiveness and drive innovation.